Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Filings indexed 1,203 across all filing types
Latest filing 2025-05-14 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice informing about an upcoming Board Meeting scheduled for 26th May 2025. It mentions that the Board will consider and approve audited financial results for the quarter and financial year ended 31st March 2025, and a proposal for an Employee Stock Option Scheme. The document references Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed companies. The document is brief (1284 characters) and serves as an intimation or announcement of a Board Meeting rather than containing the actual financial results or detailed report. Therefore, it is not an Annual Report, Interim Report, or Earnings Release. It is also not a Management Report or Capital Update. The document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement about a forthcoming Board Meeting and related agenda items, without substantive financial data or detailed report content.
2025-05-14 English
Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve As per letter attached
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for 26th May 2025. The letter references Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of Board meetings. The purpose of the meeting includes consideration and approval of audited financial results for the quarter and financial year ended 31st March 2025, and a proposal for an Employee Stock Option Scheme. The document is an announcement of a Board Meeting and does not contain the actual financial results or detailed report. It is a notification of management activity rather than a full management report or financial filing. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short (1284 characters), consistent with an announcement rather than a full report.
2025-05-14 English
As per letter attached
Regulatory Filings
2025-05-09 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of the Cost Auditor for the financial year 2024-25. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in company officials or auditors. The document includes details about the resignation and reasons but does not contain any financial statements or detailed audit results. It is an announcement of a change in auditor rather than an audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-05-09 English
As per letter attached
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a court order (Roznama Order) from the City Civil Court, Mumbai, regarding a disputed claim against the company. The document includes a summary of the court order and states that the company is evaluating the order and will take necessary actions, including the right to appeal. There is no financial data, report, or detailed analysis provided. The document is an announcement of a legal proceeding update rather than a full legal report or financial report. It is short (4050 characters) and serves as a regulatory disclosure to the stock exchanges about a material legal development. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-08 English
Action(s) taken or orders passed
Legal Proceedings Report Classification · 100% confidence The document is a formal communication addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a court order (Roznama Order) from the City Civil Court, Mumbai, regarding a disputed claim. The document includes details of the court order and the company's intended actions, but it does not contain financial statements, earnings data, or detailed management analysis. The document is an update on a legal proceeding affecting the company, which fits the category of Legal Proceedings Report. The document length is 4050 characters, which is relatively short and focused on a specific legal matter, not a full report or announcement of a report publication. Therefore, the appropriate classification is Legal Proceedings Report (LTR).
2025-05-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.